Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041190015Completed
Open-label, single-arm trial of edoxaban in portal vein thrombosis (PVT). Primary endpoint: Portal vein thrombus reduction rate. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041190015.